{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:34:22Z","timestamp":1792704862748,"version":"4.5.0"},"reference-count":17,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"abstract":"<jats:p>Abnormal trophoblast growth can cause life-threatening disorders such as ectopic pregnancy, choriocarcinoma, and placenta accreta. EnGeneIC Delivery Vehicles (EDVs) are nanocells that can promote tissue-specific delivery of drugs and may be useful to medically treat such disorders. The objective of this study was to determine whether EDVs loaded with the chemotherapeutic doxorubicin and targeting the epidermal growth factor receptor (EGFR, very highly expressed on the placental surface) can regress placental cells in vitro, ex vivo, and in vivo. In female SCID mice, EGFR-targeted EDVs induced greater inhibition of JEG-3 (choriocarcinoma cells) tumor xenografts, compared with EDVs targeting an irrelevant antigen (nontargeted EDVs) or naked doxorubicin. EGFR-targeted EDVs were more readily taken up by human placental explants ex vivo and induced increased apoptosis (M30 antibody) compared with nontargeted EDVs. In vitro, EGFR-targeted EDVs administered to JEG-3 cells resulted in a dose-dependent inhibition of cell viability, proliferation, and increased apoptosis, a finding confirmed by continuous monitoring by xCELLigence. In conclusion, EGFR-targeted EDVs loaded with doxorubicin significantly inhibited trophoblastic tumor cell growth in vivo and in vitro and induced significant cell death ex vivo, potentially mediated by increasing apoptosis and decreasing proliferation. EDVs may be a novel nanoparticle treatment for ectopic pregnancy and other disorders of trophoblast growth.<\/jats:p>","DOI":"10.1210\/en.2012-1832","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T02:07:04Z","timestamp":1357265224000},"page":"911-919","source":"Crossref","is-referenced-by-count":58,"title":["Targeted Nanoparticle Delivery of Doxorubicin Into Placental Tissues to Treat Ectopic Pregnancies"],"prefix":"10.1210","volume":"154","author":[{"given":"Tu\u2019uhevaha J.","family":"Kaitu\u2019u-Lino","sequence":"first","affiliation":[{"name":"From the Translational Obstetrics Group, the Department of Obstetrics and Gynaecology (T.J.K.-L., L.Y., L.T., S.T.), Mercy Hospital for Women, University of Melbourne, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Pattison","sequence":"first","affiliation":[{"name":"EnGeneIC Ltd (S.P., J.M., H.B.), Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louie","family":"Ye","sequence":"first","affiliation":[{"name":"From the Translational Obstetrics Group, the Department of Obstetrics and Gynaecology (T.J.K.-L., L.Y., L.T., S.T.), Mercy Hospital for Women, University of Melbourne, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tuohey","sequence":"first","affiliation":[{"name":"From the Translational Obstetrics Group, the Department of Obstetrics and Gynaecology (T.J.K.-L., L.Y., L.T., S.T.), Mercy Hospital for Women, University of Melbourne, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Sluka","sequence":"first","affiliation":[{"name":"the Ludwig Institute for Cancer Research (P.S.), Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"MacDiarmid","sequence":"first","affiliation":[{"name":"EnGeneIC Ltd (S.P., J.M., H.B.), Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Brahmbhatt","sequence":"first","affiliation":[{"name":"EnGeneIC Ltd (S.P., J.M., H.B.), Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence","family":"Johns","sequence":"first","affiliation":[{"name":"Monash Institute of Medical Research (T.J.), Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Horne","sequence":"first","affiliation":[{"name":"MRC Centre for Reproductive Health (A.W.H., J.B.), Edinburgh, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Brown","sequence":"first","affiliation":[{"name":"MRC Centre for Reproductive Health (A.W.H., J.B.), Edinburgh, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"first","affiliation":[{"name":"From the Translational Obstetrics Group, the Department of Obstetrics and Gynaecology (T.J.K.-L., L.Y., L.T., S.T.), Mercy Hospital for Women, University of Melbourne, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"2020071612083484600_B1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp0810384","article-title":"Clinical practice. Ectopic pregnancy","volume":"361","author":"Barnhart","year":"2009","journal-title":"N Engl J Med"},{"key":"2020071612083484600_B2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(05)67103-6","article-title":"Ectopic pregnancy","volume":"366","author":"Farquhar","year":"2005","journal-title":"Lancet"},{"key":"2020071612083484600_B3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"2020071612083484600_B4","doi-asserted-by":"crossref","first-page":"637094","DOI":"10.5402\/2012\/637094","article-title":"The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review","volume":"2012","author":"Skubisz","year":"2012","journal-title":"ISRN Obstet Gynecol"},{"key":"2020071612083484600_B5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccr.2007.03.012","article-title":"Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics","volume":"11","author":"MacDiarmid","year":"2007","journal-title":"Cancer Cell"},{"key":"2020071612083484600_B6","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4161\/cc.6.17.4648","article-title":"Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitors","volume":"6","author":"MacDiarmid","year":"2007","journal-title":"Cell Cycle"},{"key":"2020071612083484600_B7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.placenta.2004.10.002","article-title":"Human placental explants in culture: approaches and assessments","volume":"26","author":"Miller","year":"2005","journal-title":"Placenta"},{"key":"2020071612083484600_B8","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.addr.2004.02.014","article-title":"Nanoparticle and targeted systems for cancer therapy","volume":"56","author":"Brannon-Peppas","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"2020071612083484600_B9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd1088","article-title":"The dawning era of polymer therapeutics","volume":"2","author":"Duncan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"2020071612083484600_B10","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2174\/1381612043383467","article-title":"Targeted liposomal drug delivery in cancer","volume":"10","author":"Medina","year":"2004","journal-title":"Curr Pharm Des"},{"key":"2020071612083484600_B11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2020071612083484600_B12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nbt.1547","article-title":"Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug","volume":"27","author":"MacDiarmid","year":"2009","journal-title":"Nat Biotechnol"},{"key":"2020071612083484600_B13","first-page":"w13559","article-title":"Knocking at the door of the unborn child: engineered nanoparticles at the human placental barrier","volume":"142","author":"Buerki-Thurnherr","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"2020071612083484600_B14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nnano.2011.65","article-title":"Nanotoxicology: nanoparticles versus the placenta","volume":"6","author":"Keelan","year":"2011","journal-title":"Nat Nanotechnol"},{"key":"2020071612083484600_B15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.reprotox.2008.06.008","article-title":"Kinetics of gold nanoparticles in the human placenta","volume":"26","author":"Myllynen","year":"2008","journal-title":"Reprod Toxicol"},{"key":"2020071612083484600_B16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/wnan.53","article-title":"Transplacental transport of nanomaterials","volume":"1","author":"Saunders","year":"2009","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"2020071612083484600_B17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nnano.2011.41","article-title":"Silica and titanium dioxide nanoparticles cause pregnancy complications in mice","volume":"6","author":"Yamashita","year":"2011","journal-title":"Nat Nanotechnol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/2\/911\/8983326\/endo0911.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/2\/911\/8983326\/endo0911.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T15:13:29Z","timestamp":1594912409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/154\/2\/911\/2423708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2012-1832","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718012616.793477196","asserted-by":"object"}]},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]}}}